About Lanreotide
            
            Class: | Somatostatin analogue  
Use: | Treatment of acromegaly, neuroendocrine tumors (NETs), and for the management of symptoms associated with carcinoid syndrome and VIPomas  
Adult dose: | 60 mg administered as a subcutaneous injection every 28 days; dose may be adjusted based on clinical response  
Pediatric dose: | Safety and efficacy not established in pediatric populations; use is not recommended  
Side effects: | Common side effects include diarrhea, abdominal pain, nausea, vomiting, fa
         
        
            
                
                
                    
                        Drug Class
                    
                    Somatostatin analogue
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of acromegaly, neuroendocrine tumors (NETs), and for the management of symptoms associated with carcinoid syndrome and VIPomas
                 
                
                
                    
                        Storage Requirements
                    
                    Store in a refrigerator (2°C to 8°C); do not freeze; protect from light; may be kept at room temperature (up to 25°C) for up to 14 days prior to use
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Ipsen Pharma Biotech, FRANCE
                    
                    
                    Package Size
                    1 Pre-filled Syringe
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 4547.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        60 mg administered as a subcutaneous injection every 28 days; dose may be adjusted based on clinical response
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric populations; use is not recommended
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include diarrhea, abdominal pain, nausea, vomiting, fatigue, and injection site reactions
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to lanreotide or any component of the formulation; gallbladder disease; severe liver impairment
         
        
        
            
                Important Warnings
            
            Monitor for gallbladder disease; may affect glucose metabolism; caution in patients with diabetes; potential for QT prolongation; not for intravenous use
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.